Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
Front Immunol. 2023 Dec 20;14:1297577. doi: 10.3389/fimmu.2023.1297577. eCollection 2023.
Front Immunol. 2023.
PMID: 38187374
Free PMC article.
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Valko Z, Megyesfalvi Z, Schwendenwein A, Lang C, Paku S, Barany N, Ferencz B, Horvath-Rozsas A, Kovacs I, Schlegl E, Pozonec V, Boettiger K, Rezeli M, Marko-Varga G, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Grusch M, Laszlo V, Dome B, Schelch K.
Valko Z, et al. Among authors: schlegl e.
Br J Cancer. 2023 May;128(10):1850-1861. doi: 10.1038/s41416-023-02219-9. Epub 2023 Mar 14.
Br J Cancer. 2023.
PMID: 36918717
Free PMC article.
Item in Clipboard
Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas.
Papp E, Steib A, Abdelwahab EM, Meggyes-Rapp J, Jakab L, Smuk G, Schlegl E, Moldvay J, Sárosi V, Pongracz JE.
Papp E, et al. Among authors: schlegl e.
BMJ Open Respir Res. 2020 Jun;7(1):e000505. doi: 10.1136/bmjresp-2019-000505.
BMJ Open Respir Res. 2020.
PMID: 32527872
Free PMC article.
Item in Clipboard
[Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy].
Radeczky P, Megyesfalvi Z, Fillinger J, László V, Rásó E, Moldvay J, Schlegl E, Barbai T, Bogos K, Tímár J, Rényi-Vámos F, Hegedűs B, Döme B.
Radeczky P, et al. Among authors: schlegl e.
Magy Onkol. 2021 Jun 3;65(2):103-111. Epub 2021 May 8.
Magy Onkol. 2021.
PMID: 34081758
Free article.
Hungarian.
Item in Clipboard
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.
Radeczky P, Megyesfalvi Z, Laszlo V, Fillinger J, Moldvay J, Raso E, Schlegl E, Barbai T, Timar J, Renyi-Vamos F, Dome B, Hegedus B.
Radeczky P, et al. Among authors: schlegl e.
Transl Lung Cancer Res. 2021 Feb;10(2):675-684. doi: 10.21037/tlcr-20-754.
Transl Lung Cancer Res. 2021.
PMID: 33718013
Free PMC article.
Item in Clipboard
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy.
Ghimessy AK, Gellert A, Schlegl E, Hegedus B, Raso E, Barbai T, Timar J, Ostoros G, Megyesfalvi Z, Gieszer B, Moldvay J, Renyi-Vamos F, Lohinai Z, Hoda MA, Klikovits T, Klepetko W, Laszlo V, Dome B.
Ghimessy AK, et al. Among authors: schlegl e.
Cancers (Basel). 2019 Oct 9;11(10):1514. doi: 10.3390/cancers11101514.
Cancers (Basel). 2019.
PMID: 31600989
Free PMC article.
Item in Clipboard
Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making.
Schlegl E, Ducournau P, Ruof J.
Schlegl E, et al.
Pharmaceut Med. 2017;31(4):213-216. doi: 10.1007/s40290-017-0197-3. Epub 2017 Jul 11.
Pharmaceut Med. 2017.
PMID: 28824273
Free PMC article.
Item in Clipboard
Cite
Cite